114 related articles for article (PubMed ID: 906832)
1. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
2. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
3. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
4. Potential hypolipidemic agents. XVIII. Synthesis and lipid-lowering properties of 2-(dibenzothiophenoxy)-2-methylpropionates and related compounds.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):337-60. PubMed ID: 747093
[No Abstract] [Full Text] [Related]
5. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
6. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
[No Abstract] [Full Text] [Related]
7. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
Ginocchio AV; Metz G
Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
[TBL] [Abstract][Full Text] [Related]
8. Hypolipemic activity of clofibrate-related compounds.
Metz G; Specker M
Arzneimittelforschung; 1975 Nov; 25(11):1686-92. PubMed ID: 1243074
[TBL] [Abstract][Full Text] [Related]
9. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
[No Abstract] [Full Text] [Related]
10. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658
[No Abstract] [Full Text] [Related]
11. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids.
Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE
Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095
[No Abstract] [Full Text] [Related]
12. The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
Gustafsson K; Kiessling H
Z Versuchstierkd; 1982; 24(5-6):262-70. PubMed ID: 7170838
[No Abstract] [Full Text] [Related]
13. [Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids].
Kwapiszewski W; Borkowski L
Acta Pol Pharm; 1987; 44(2):121-31. PubMed ID: 3434313
[No Abstract] [Full Text] [Related]
14. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
16. [Fenofibrate: chemical development and differences with clofibrate (author's transl)].
Boucherle A
Nouv Presse Med; 1980 Dec; 9(49):3721-3. PubMed ID: 7208336
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
18. Hypolipidemic activity of Indan--1--acetic acids.
Adak M; Gupta JK
Nepal Med Coll J; 2006 Mar; 8(1):22-6. PubMed ID: 16827085
[TBL] [Abstract][Full Text] [Related]
19. The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
Gustafsson K; Kiessling H
Z Versuchstierkd; 1982; 24(5-6):271-7. PubMed ID: 7170839
[No Abstract] [Full Text] [Related]
20. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Davies JE; Kellett DN
Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
